dementia
Conditions
Interventions
Participants in the active group take one packet of Yokukansankachimpihange, twice a day, for 4 weeks. They are asked to keep their diet and daily activity as usual as possible.
Those in the control g
Sponsors
Polyene Project, Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The following types of subjects are invited to the trial: those with intermediate physical strength, easy fatigability and irritability, insomnia, and mild psychotic symptoms.
Exclusion criteria
Exclusion criteria: The following subjects are excluded: those with very week digestive tracts; those with severe disorders of internal organs (including severe blood and metabolic disorders), or histories of them; those with drug allergy; and also those who doctors in charge of the trial think are inappropriate for the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Yokukansankachimpihange is administered for 4 weeks to participants with mild dementia, and changes in core symptoms of dementia are compared with those in the control group. | — |
Secondary
| Measure | Time frame |
|---|---|
| Yokukansankachimpihange is administered for 4 weeks to participants with mild dementia, and changes in peripheral symptoms of dementia are compared with those in the control group. | — |
Countries
Japan
Contacts
Public ContactKei Hamazaki
Polyene Project, Inc. Department of Clinical Trial Management
Outcome results
None listed